Immunic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt
CEODaniel Vitt
Employees91
Employees91
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees91
Employees91
IMUX Key Statistics
Market cap80.46M
Market cap80.46M
Price-Earnings ratio-0.86
Price-Earnings ratio-0.86
Dividend yield—
Dividend yield—
Average volume1.60M
Average volume1.60M
High today$0.8743
High today$0.8743
Low today$0.8043
Low today$0.8043
Open price$0.84
Open price$0.84
Volume1.39M
Volume1.39M
52 Week high$1.73
52 Week high$1.73
52 Week low$0.561
52 Week low$0.561
IMUX News
TipRanks 13h
Immunic initiated with a Buy at LadenburgLadenburg analyst Aydin Huseynov initiated coverage of Immunic (IMUX) with a Buy rating and $3 price target Published first on TheFly – the ultimate source for...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.